Substances and methods for treating macular degeneration
The present invention relates to a substance that increases IRAK-M expression and/or IRAK-M activity for use in a method of treating or preventing macular degeneration in a subject. The substance may be one or more of a small molecule, a nucleic acid, a vector virion, a polypeptide, a nucleic acid s...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
23.08.2024
|
Subjects | |
Online Access | Get full text |
Cover
Summary: | The present invention relates to a substance that increases IRAK-M expression and/or IRAK-M activity for use in a method of treating or preventing macular degeneration in a subject. The substance may be one or more of a small molecule, a nucleic acid, a vector virion, a polypeptide, a nucleic acid system, a viral vector system, or a pharmaceutical composition.
本发明涉及提高IRAK-M表达和/或IRAK-M活性的物质,其用于在对象中治疗或预防黄斑变性的方法中。所述物质可以是小分子、核酸、载体病毒体、多肽、核酸系统、病毒载体系统或药物组合物中的一种或更多种。 |
---|---|
Bibliography: | Application Number: CN20228088748 |